The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Weill Digital Health Series

Weill Digital Health Series banner

 

In three 1-hour panel discussions, the Weill Digital Health Series invites a panel of experts to discuss the increased use of digital technologies for the improvement of the healthcare system and services that would result in better patient wellness, outcome, and cost management. The series focuses on diverse topics, including intellectual property (IP) and market trends, regulatory matters, challenges of reimbursement, and investment opportunities.

 

Lisa Placanica Ph.D., CLP Moderator:
Lisa Placanica, Senior Managing Director, Center for Technology Licensing at Weill Cornell Medicine (WCM)

 

 

 

 

 


 

Series 1: Digital Health Innovations – What They Are, How to Protect Them, and Commercialization Strategies

Date: March 12, 2021 12 PM – 1 PM (ET)

 

The term digital health has evolved over the years and includes various types of technologies, including telemedicine, digital therapeutics, mobile health, wearables, remote monitoring, etc. During the first session of the series, our panel of experts will provide a snapshot of the industry, will talk about strategies to protect and commercialize digital health technologies, and will address the acceleration of the digital transformation.

 

Panelists:

  • Kathryn Bowsher, Commercial Strategist, ACT ONE Healthcare
  • Peter Fleischut, Sr VP & Chief Transformation Officer, Digital Health: Innovation Center, NY Presbyterian
  • Jason Novak, Partner, Precision Medicine and Digital Health Practice Group, Haynes and Boone
  • Roger Kuan, Partner, Chair – Precision Medicine and Digital Health Practice Group, Haynes and Boone
  • Anshu Vaish, MD, Director, Data Science External Innovation Janssen Research & Development, LLC

 

Register here:

 


 

Series 2: Regulatory Landscapes and Reimbursement Strategies and Why it Matters

Date: 1st week of April

 

in 2017, the FDA launched its Digital Health Action Plan with legislation specifically targeting digital health, in which it intends to harness the potential of digital health in a conscientious manner. In this second session, our guest experts will present an overview of the regulatory landscape and the challenges related to privacy and data protection. They will also address the future of reimbursement for digital health products.

 

Registration for this event will be available soon. Please check back.

 


 

Series 3: Securing Financing and the Founders Experience

Date: 1st week of May

 

Investment in the U.S. digital health sector has significantly increased from $7.5B in 2019 to $14.1B in funding in 2020 [1]. With that number in mind, in the last session of the series, we bring together founders and investors to discuss the increased investors’ interest in digital health innovations, the investment opportunities, and the founders’ experience in this sector.

 

Registration for this event will be available soon. Please check back.

 

 

[1] DeSilva J., & Zweig J. 2020 Market Insights Report: Chasing a new equilibrium. Rock Health Report.